Suppr超能文献

膀胱癌中的分子标志物:在诊断、预后和治疗中的应用

Molecular Markers in Urinary Bladder Cancer: Applications for Diagnosis, Prognosis and Therapy.

作者信息

Rasteiro Ana Mafalda, Sá E Lemos Eva, Oliveira Paula A, Gil da Costa Rui M

机构信息

CEDIVET, Laboratório Clínico Veterinário, 4200-071 Porto, Portugal.

Garden Veterinary Group, Chippenham SN15 1NQ, UK.

出版信息

Vet Sci. 2022 Feb 28;9(3):107. doi: 10.3390/vetsci9030107.

Abstract

Cancer of the urinary bladder is a neoplasm with considerable importance in veterinary medicine, given its high incidence in several domestic animal species and its life-threatening character. Bladder cancer in companion animals shows a complex and still poorly understood biopathology, and this lack of knowledge has limited therapeutic progress over the years. Even so, important advances concerning the identification of tumour markers with clinical applications at the diagnosis, prognosis and therapeutic levels have recently been made, for example, the identification of pathological mutations. Those advances are now facilitating the introduction of targeted therapies. The present review will address such advances, focusing on small animal oncology and providing the reader with an update on this field. When appropriate, comparisons will be drawn with bladder cancer in human patients, as well as with experimental models of the disease.

摘要

膀胱癌是一种在兽医学中具有相当重要性的肿瘤,因为它在几种家养动物物种中发病率很高,且具有危及生命的特性。伴侣动物中的膀胱癌表现出复杂且仍未被充分理解的生物病理学,多年来,这种知识的匮乏限制了治疗进展。即便如此,最近在肿瘤标志物的识别方面取得了重要进展,这些标志物在诊断、预后和治疗水平上具有临床应用价值,例如病理突变的识别。这些进展现在正推动靶向治疗的引入。本综述将探讨这些进展,重点关注小动物肿瘤学,并为读者提供该领域的最新信息。在适当的时候,将与人类患者的膀胱癌以及该疾病的实验模型进行比较。

相似文献

2
Comparative Aspects of BRAF Mutations in Canine Cancers.
Vet Sci. 2015 Aug 24;2(3):231-245. doi: 10.3390/vetsci2030231.
3
Predicting progression of bladder urothelial carcinoma using microRNA expression.
BJU Int. 2013 Nov;112(7):1027-34. doi: 10.1111/j.1464-410X.2012.11748.x. Epub 2013 Feb 6.
4
[Personalised medicine in urothelial bladder cancer].
Aktuelle Urol. 2019 Sep;50(5):502-508. doi: 10.1055/a-0927-6725. Epub 2019 Jun 13.
6
Current concepts of tumor markers in bladder cancer.
Urol Clin North Am. 2002 Feb;29(1):229-34. doi: 10.1016/s0094-0143(02)00008-3.
8
New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer.
Korean J Urol. 2015 Aug;56(8):553-64. doi: 10.4111/kju.2015.56.8.553. Epub 2015 Jul 31.
9
Bladder cancer: translating molecular genetic insights into clinical practice.
Hum Pathol. 2011 Apr;42(4):455-81. doi: 10.1016/j.humpath.2010.07.007. Epub 2010 Nov 24.
10

引用本文的文献

2
Metastatic urothelial carcinoma in multiple appendicular muscles of a cat.
JFMS Open Rep. 2025 Jan 6;11(1):20551169241303217. doi: 10.1177/20551169241303217. eCollection 2025 Jan-Jun.
3
Uncommon presentation of transitional cell carcinoma: A case report of hand involvement.
Clin Case Rep. 2024 Sep 20;12(9):e9358. doi: 10.1002/ccr3.9358. eCollection 2024 Sep.
5
Urinary exosomes: Potential diagnostic markers and application in bladder cancer.
Heliyon. 2024 Jun 10;10(12):e32621. doi: 10.1016/j.heliyon.2024.e32621. eCollection 2024 Jun 30.
10
Editorial: Special Issue "Addressing New Therapeutic Strategies Using Models".
Vet Sci. 2023 Mar 17;10(3):230. doi: 10.3390/vetsci10030230.

本文引用的文献

1
Prognostic role of ΔNp63 expression in canine transitional cell carcinoma of the urinary bladder.
Open Vet J. 2021 Oct-Dec;11(4):700-706. doi: 10.5455/OVJ.2021.v11.i4.22. Epub 2021 Dec 15.
2
3
Cell-Free DNA as a Diagnostic and Prognostic Biomarker in Dogs With Tumors.
Front Vet Sci. 2021 Sep 16;8:735682. doi: 10.3389/fvets.2021.735682. eCollection 2021.
7
Unraveling the Epigenetic Role and Clinical Impact of Histone Deacetylases in Neoplasia.
Diagnostics (Basel). 2021 Jul 26;11(8):1346. doi: 10.3390/diagnostics11081346.
8
Phase I/II Trial of Vemurafenib in Dogs with Naturally Occurring, -mutated Urothelial Carcinoma.
Mol Cancer Ther. 2021 Nov;20(11):2177-2188. doi: 10.1158/1535-7163.MCT-20-0893. Epub 2021 Aug 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验